Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
29 March, 2015 21:32 IST
Dr Reddys gets USFDA nod for Sildenafil tablets
Source: IRIS | 19 Nov, 2012, 09.43AM
Comments  |  Post Comment

Dr Reddys Laboratories, an integrated global pharmaceutical company,  announced that it has launched Sildenafil tablets (20 mg), a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

It has received approval by the United States Food & Drugs Administration (USFDA) for ANDA Sildenafil tablets.

The Revatio brand had US sales of approximately USD 338.67 million for the most recent 12 months ending September 2012 according to IMS health.

Shares of the company gained Rs 16, or 0.91%, to trade at Rs 1,773.35. The total volume of shares traded was 755 at the BSE (9.32 a.m., Monday).



Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Tata Teleservices wins spectrum in 800 MHz band in Mumbai & Maharashtra - 27-Mar-2015 18:12
Fortis to sell Singapore hospital to Concord Medical Services - 27-Mar-2015 16:25
Strides Arcolab launches generic drug Sofosbuvir in India - 27-Mar-2015 15:16
L&T Construction wins orders worth Rs 17.11 bn - 27-Mar-2015 10:20
Reliance Jio Infocomm bids total Rs 100.77 bn in spectrum auctions - 27-Mar-2015 10:09
RCom bids total Rs 42.99 bn in spectrum auctions - 27-Mar-2015 10:01
NTPC becomes first PSU to issue bonus debentures - 27-Mar-2015 09:53
Bharti Airtel acquires Prime Spectrum - 27-Mar-2015 09:13
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer